Iron Status Pregnant Women and Infants: Research Needs for Screening and Supplementation Strategies in the US (Day 1)

The workshop outcome will be the identification and prioritization of research gaps and needs. To develop research recommendations focused on clarifying the benefit and/or harms associated with (a) screening pregnant women and infants (6-24 mos.) for iron deficiency and (b) supplementing replete pregnant women and infants (6-24 mos.) with iron. In 2015 these preventive activities were determined by USPSTF to lack sufficient evidence to demonstrate benefit or harm. Pregnant women are among the group most likely to have inadequate intakes of iron. During pregnancy, plasma volume and red cell mass expand due to dramatic increases in maternal red blood cell production [2]. As a result of this expansion and to meet the needs of the fetus and placenta, the amount of iron that women need increases during pregnancy. Iron deficiency during pregnancy increases the risk of maternal and infant mortality, premature birth, and low birth weight. This workshop is in keeping with the mission of ODS and the Dietary Supplement Health and Education Act (DSHEA) of 1994 defined dietary supplements as products intended to supplement the diet. DSHEA also established the Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) in the U.S. Department of Health and Human Services (HHS), which began operations in November 1995. For more information go to https://ods.od.nih.gov/Research/Iron.aspxAir date: 9/28/2016 8:00:00 AM
Source: Videocast - All Events - Category: Journals (General) Tags: Upcoming Events Source Type: video